TIOTROPIUM INHALATION SOLUTION FOR NEBULIZATION

The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in...

Full description

Saved in:
Bibliographic Details
Main Authors DHUPPAD ULHAS, DHATRAK CHANDRAKANT, RAJURKAR SURESH, KASLIWAL ALKESH, KOPPENHAGEN FRANEISCUS, CHAUDHURI SURAJIT
Format Patent
LanguageChinese
English
Published 26.11.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a sterile pharmaceutical composition comprising tiotropium or a pharmaceutically acceptable salt thereof, for inhalation via nebulization to a subject (e.g. a human). The invention also relates to a process for preparing the pharmaceutical composition and its use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) in a subject. 本发明涉及一种用于经由雾化由受试者(例如人)吸入的包含泰乌托品或其药学上可接受的盐的无菌药物组合物。本发明还涉及一种用于制备所述药物组合物的方法以及所述药物组合物在治疗受试者的呼吸系统疾病如慢性阻塞性肺病(COPD)中的用途。
Bibliography:Application Number: CN202110836679